HEXAGONHexagon Nutrition Limited
FMCG · Packaged Foods · NSE · as of 2026-10-26 (delayed ~30 min in market hours)
Hexagon Nutrition Limited operates as a nutraceutical business focused on the development and supply of micronutrient premixes, clinical nutrition, and therapeutic food in India and South Africa, Malaysia, Ethiopia, France, French Polynesia, Ghana, Indonesia, Kenya, Madagascar, Mozambique, Papua New Guinea, Nigeria, Philippines, Qatar, UAE, Mauritius, Brazil, Bangladesh, Rwanda, and Internationally. The company provides ready-to-use supplementary food (RUSF), ready-to-use therapeutic food (RUTF), health and wellness products, and home fortification solutions. It also develops functional foods, dietary supplements, plant-based nutritional alternatives, maternal and geriatric nutrition products, and condition-specific formulations aimed at managing lifestyle disorders, such as diabetes, cardiovascular health, and obesity. It serves food companies and nutraceutical industry. The company was founded in 1991 and is headquartered in Mumbai, India.
Price & Volume
Loading chart…
Key Ratios
“—” means the figure isn't meaningful or isn't published for this company: ROE and Debt/Equity are undefined when shareholder equity is negative (check P/B — negative means negative equity), and DII/MF holding splits aren't provided by our current data source.
Active Pattern Signals
None of the 16 pattern scanners currently detects a setup on HEXAGON — signals appear here automatically when one forms (checked on every data refresh). The Trade Plan on the right always provides stop-loss and target levels regardless.
The picture
- • Revenue growth: 43.2% YoY
- • Profit growth: 24.5% YoY
- • Debt/Equity: 0.14
- • Volume trend: 1.7x baseline
- • Max drawdown (1y): 21%
- • Beta: 1.22
Bull case
- • Revenue growth: 43.2% YoY
- • Profit growth: 24.5% YoY
- • Debt/Equity: 0.14
- • Volume trend: 1.7x baseline
Bear case
- • Valuation vs sector: P/E 34.0 vs sector 20.8
- • Dividend yield: 0.51%
- • RSI: 34
- • MACD: bearish
Key risks
- • Momentum is fading versus the broader market
- • Valuation vs sector: P/E 34.0 vs sector 20.8
- • Dividend yield: 0.51%
Algorithmic analysis for research only — not SEBI-registered investment advice.
Trade Plan
Stop = 20-day support with a 2.5×ATR risk cap (ATR ₹3.61). Levels recompute on every data refresh. Position sizing and execution are yours — this is analysis, not advice.